Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Fakra

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
JMIR Formative Research|April 3, 2024
Prospective Acceptability of Digital Therapy for Major Depressive Disorder in France: Multicentric Real-Life StudyOdile Amiot, Anne Sauvaget, Isabelle Alamome, et al.
European Journal of Psychotraumatology|April 13, 2023
EMDR for symptoms of depression, stress and burnout in health care workers exposed to COVID-19 (HARD): A study protocol for a trial within a cohort studyAgnès Caille, Aude Allemang-Trivalle, Myriam Blanchin, et al.
Schizophrenia (Heidelberg, Germany)|March 20, 2024
Blunted brain responses to neutral faces in healthy first-degree relatives of patients with schizophrenia: an image-based fMRI meta-analysisAnna M Fiorito, Giuseppe Blasi, Jérôme Brunelin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 21, 2025
High Psychological Impact of Covid-19 on French Healthcare Workers: An Observational Cohort Study of PTSD, Depression and Burn-OutWissam El-Hage, Alexandre Lemé, Myriam Blanchin, et al.
Trials|December 29, 2021
Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trialJerome Brunelin, Marine Mondino, Julie Haesebaert, et al.
Schizophrenia Research|August 20, 2015
CX3CR1 is dysregulated in blood and brain from schizophrenia patientsAurélie Bergon, Raoul Belzeaux, Magali Comte, et al.
Clinical Trials (London, England)|February 26, 2026
Shaping the future of clinical trials through strategic foresightSharon Lee, Jeff McIntyre, Tracey Robertson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 24, 2023
Understanding the potential of digital therapies in implementing the standard of care for depression in EuropePhilippe Courtet, Odile Amiot, Enrique Baca-Garcia, et al.
Drug Safety|March 15, 2025
QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZMona Gerentes, Mohamed Lajnef, Andrei Szöke, et al.
Brain, Behavior, and Immunity|April 29, 2026
Peripheral immune-vascular correlates of suicidal thoughts and behaviors in bipolar disorder and schizophrenia: cross-sectional and prospective analyses from the FACE-BD and FACE-SZ cohortsAiste Lengvenyte, Wahid Boukouaci, Ching-Lien Wu, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
JMIR Formative Research|April 3, 2024
Prospective Acceptability of Digital Therapy for Major Depressive Disorder in France: Multicentric Real-Life StudyOdile Amiot, Anne Sauvaget, Isabelle Alamome, et al.
European Journal of Psychotraumatology|April 13, 2023
EMDR for symptoms of depression, stress and burnout in health care workers exposed to COVID-19 (HARD): A study protocol for a trial within a cohort studyAgnès Caille, Aude Allemang-Trivalle, Myriam Blanchin, et al.
Schizophrenia (Heidelberg, Germany)|March 20, 2024
Blunted brain responses to neutral faces in healthy first-degree relatives of patients with schizophrenia: an image-based fMRI meta-analysisAnna M Fiorito, Giuseppe Blasi, Jérôme Brunelin, et al.
Health Expectations : an International Journal of Public Participation in Health Care and Health Policy|August 21, 2025
High Psychological Impact of Covid-19 on French Healthcare Workers: An Observational Cohort Study of PTSD, Depression and Burn-OutWissam El-Hage, Alexandre Lemé, Myriam Blanchin, et al.
Trials|December 29, 2021
Examining transcranial random noise stimulation as an add-on treatment for persistent symptoms in schizophrenia (STIM'Zo): a study protocol for a multicentre, double-blind, randomized sham-controlled clinical trialJerome Brunelin, Marine Mondino, Julie Haesebaert, et al.
Schizophrenia Research|August 20, 2015
CX3CR1 is dysregulated in blood and brain from schizophrenia patientsAurélie Bergon, Raoul Belzeaux, Magali Comte, et al.
Clinical Trials (London, England)|February 26, 2026
Shaping the future of clinical trials through strategic foresightSharon Lee, Jeff McIntyre, Tracey Robertson, et al.
European Psychiatry : the Journal of the Association of European Psychiatrists|October 24, 2023
Understanding the potential of digital therapies in implementing the standard of care for depression in EuropePhilippe Courtet, Odile Amiot, Enrique Baca-Garcia, et al.
Drug Safety|March 15, 2025
QT Interval, Antipsychotics and Correlates Among Patients with Schizophrenia: Cross-Sectional Data from the Multicentric Real-World FACE-SZMona Gerentes, Mohamed Lajnef, Andrei Szöke, et al.
Brain, Behavior, and Immunity|April 29, 2026
Peripheral immune-vascular correlates of suicidal thoughts and behaviors in bipolar disorder and schizophrenia: cross-sectional and prospective analyses from the FACE-BD and FACE-SZ cohortsAiste Lengvenyte, Wahid Boukouaci, Ching-Lien Wu, et al.
Pageof 7